Riskpilot← Back to searchSign inGet full accessLantmännen Medical AB
ABActiveOrg 5565309720Sankt Göransgatan 160 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 19960 employees
Revenue 2024
SEK 43K
EBITDA margin
-8625.6%
+67% vs 2023
Equity ratio
61.1%
Financial strength
Net profit 2024
SEK 2,1M
+69233% vs 2023
| Revenue | SEK 43K | — |
| EBITDA | SEK -3,7M | +67% |
| Net profit | SEK 2,1M | +69233% |
| Total assets | SEK 67,5M | +12% |
| Equity | SEK 41,3M | +5% |
| Employees | 0 | — |
Legal name
Lantmännen Medical AB
Org number
5565309720
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3 april 1996
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska förvärva, äga, förvalta och utveckla patent och andra immateriella rättigheter, exploatera samt upplåta licens- och tillverkningsrättigheter till sådana immateriella rättigheter samt idka därmed förenlig verksamhet.
Address
Sankt Göransgatan 160 A
Phone
+4686574200
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 43 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −21 223 | −14 465 | −16 033 | −11 170 | −3 709 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −21 223 | −14 465 | −16 033 | −11 170 | −3 709 |
| Net financials | 144 | 295 | 789 | 1 848 | 2 076 |
| Profit before tax | 694 | −8 | −6 | −3 | 2 074 |
| Tax | −0 | −120 | −0 | −0 | −0 |
| Net profit | 694 | −128 | −6 | −3 | 2 074 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 42 494 | 66 295 | 59 529 | 60 223 | 67 481 |
| Equity | 39 314 | 39 186 | 39 180 | 39 176 | 41 250 |
| Long-term debt | 0 | 20 000 | 20 000 | 20 000 | 26 000 |
| Short-term debt | 3 180 | 7 109 | 349 | 1 047 | 231 |
| Total debt | 3 180 | 27 109 | 20 349 | 21 047 | 26 231 |
EBITDA margin
-8625.6%
This company
15.8%
Market median
-54692% vs market
20202024
Equity ratio
61.1%
This company
38.2%
Market median
+60% vs market
20202024
Return on equity
5.0%
This company
18.4%
Market median
-73% vs market
20202024
Net profit margin
4823.3%
This company
8.1%
Market median
+59447% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AF Chief Auditor | Chief Auditor | 2022 |
LA Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
SM Chief Auditor | Chief Auditor | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Chairman | 2021 | |
| Former (2) | ||
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lantmännen ek för
Lantmännen Medical AB Board members of Lantmännen Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Fredrik Rodéhn | Chief Auditor | 0 companies |
| Sanna Maria Therese Finnbäck | Chief Auditor | 0 companies |
| Lars Axel Franzén | Chief Executive Officer | 0 companies |
| Per Gunnar Arfvidsson | Deputy Board Member | 0 companies |
| Marcus Jan Arendszoon Hubrecht | Chairman | 0 companies |
| Stefan Lange | Board of Directors | 0 companies |
| Fredrik Franz Johan Wilhelm Buch | Board of Directors | 0 companies |